Global Companion Animal Diagnostics Market by Technology (Molecular Diagnostics, Clinical Biochemistry) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
No. Of Pages: 214
Pub. Date: 2021-10-21
TABLE OF CONTENT
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Companion Animal Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Companion Animal Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Companion Animal Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Companion Animal Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Companion Animal Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Companion Animal Diagnostics Market Size and Y-o-Y Growth
4.5.2 Companion Animal Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Companion Animal Diagnostics Market Analysis and Forecast by Technology
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Technology
5.1.2 Basis Point Share (BPS) Analysis by Technology
5.1.3 Absolute $ Opportunity Assessment by Technology
5.2 Companion Animal Diagnostics Market Size Forecast by Technology
5.2.1 Molecular Diagnostics
5.2.2 Clinical Biochemistry
5.3 Market Attractiveness Analysis by Technology
Chapter 6 Global Companion Animal Diagnostics Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Companion Animal Diagnostics Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Companion Animal Diagnostics Analysis and Forecast
8.1 Introduction
8.2 North America Companion Animal Diagnostics Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Companion Animal Diagnostics Market Size Forecast by Technology
8.6.1 Molecular Diagnostics
8.6.2 Clinical Biochemistry
8.7 Basis Point Share (BPS) Analysis by Technology
8.8 Absolute $ Opportunity Assessment by Technology
8.9 Market Attractiveness Analysis by Technology
Chapter 9 Europe Companion Animal Diagnostics Analysis and Forecast
9.1 Introduction
9.2 Europe Companion Animal Diagnostics Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Companion Animal Diagnostics Market Size Forecast by Technology
9.6.1 Molecular Diagnostics
9.6.2 Clinical Biochemistry
9.7 Basis Point Share (BPS) Analysis by Technology
9.8 Absolute $ Opportunity Assessment by Technology
9.9 Market Attractiveness Analysis by Technology
Chapter 10 Asia Pacific Companion Animal Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Companion Animal Diagnostics Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Companion Animal Diagnostics Market Size Forecast by Technology
10.6.1 Molecular Diagnostics
10.6.2 Clinical Biochemistry
10.7 Basis Point Share (BPS) Analysis by Technology
10.8 Absolute $ Opportunity Assessment by Technology
10.9 Market Attractiveness Analysis by Technology
Chapter 11 Latin America Companion Animal Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Latin America Companion Animal Diagnostics Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Companion Animal Diagnostics Market Size Forecast by Technology
11.6.1 Molecular Diagnostics
11.6.2 Clinical Biochemistry
11.7 Basis Point Share (BPS) Analysis by Technology
11.8 Absolute $ Opportunity Assessment by Technology
11.9 Market Attractiveness Analysis by Technology
Chapter 12 Middle East & Africa (MEA) Companion Animal Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Companion Animal Diagnostics Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Companion Animal Diagnostics Market Size Forecast by Technology
12.6.1 Molecular Diagnostics
12.6.2 Clinical Biochemistry
12.7 Basis Point Share (BPS) Analysis by Technology
12.8 Absolute $ Opportunity Assessment by Technology
12.9 Market Attractiveness Analysis by Technology
Chapter 13 Competition Landscape
13.1 Companion Animal Diagnostics Market: Competitive Dashboard
13.2 Global Companion Animal Diagnostics Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 Thermo Fisher Scientific
13.3.2 Idexx Laboratories Inc
13.3.3 Heska Corporation
13.3.4 Zoetis Inc
13.3.5 Neogen
